CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 55 enrolled
Drug / intervention
Nucleus CI422 Cochlear Implant with N6 Sound Processordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01867008
NCT01867008N/ACompleted
CompareCT.gov

Safety and Efficacy of the Cochlear Nucleus CI422 Cochlear Implant in Adults

Cochlear·interventional·Posted Jun 3, 2013·Updated Jan 25, 2021

In Brief

A clinical study evaluating Nucleus CI422 Cochlear Implant with N6 Sound Processor for Hearing Loss. Completed, enrolled 55 participants across 2 sites.

Detailed Summary

Clinical study to evaluate the safety and efficacy of the Cochlear™ Nucleus® CI422 cochlear implant for new cochlear implant adult recipients with broader requirements to be considered an eligible candidate.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 3, 2013
Enrollment StartAug 1, 2013
Primary CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.1 years ago

Interventions

Nucleus CI422 Cochlear Implant with N6 Sound Processordevice